Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Neurosurgery|August 22, 2002
Unusual migration of the distal catheter of a ventriculoperitoneal shunt into the heart: case reportJames L Frazier, Paul P Wang, Salil H Patel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2016
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 TrialJeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, et al.
Journal of Child and Adolescent Psychopharmacology|March 26, 2025
A Blueprint for Translational Precision Medicine in Autism Spectrum Disorder and Related Neurogenetic SyndromesRobyn P Thom, Tracy L Warren, Suha Khan, et al.
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Journal of Autism and Developmental Disorders|March 1, 2020
Access to Dental Visits and Correlates of Preventive Dental Care in Children with Autism Spectrum DisorderRachel M Fenning, Robin Steinberg-Epstein, Eric M Butter, et al.
Science Translational Medicine|September 21, 2012
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trialElizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|April 23, 2005
Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion SyndromeCarrie E Bearden, Abbas F Jawad, David R Lynch, et al.
The American Journal of Psychiatry|September 1, 2004
Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndromeCarrie E Bearden, Abbas F Jawad, David R Lynch, et al.
Journal of Autism and Developmental Disorders|November 26, 2013
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label studyCraig A Erickson, Jeremy M Veenstra-Vanderweele, Raun D Melmed, et al.
Expert Review of Neurotherapeutics|May 4, 2026
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndromeHannah M Rea, Julia T Mattson, Vardan Arutiunian, et al.
Pageof 4